GGrantIndex
← Leaderboards

A.T. Still University Of Health Sciences

Kirksville, MO

Compare ↔
$6,355,119
Total funding
15
Grants

Funding over time

peak $528.2K · FY2005–21
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$6,355,119 · 15

By mechanism

R01$2,645,982 · 6
R15$1,982,209 · 7
R25$1,579,925 · 1
R21$147,003 · 1

Investigators at A.T. Still University Of Health Sciences

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Tim D. Ostrowski$387,4031 gr2Tara L McIsaac$384,3171 gr3Yohei Norimatsu$382,3431 gr

All-Time

Most funded here, all years

1Nissar A Darmani$2,488,6583 gr2Richard J Cenedella$1,975,9862 gr3Stephen Douglas Laird$1,158,6571 gr4Margaret Ann Wilson$421,2681 gr5Tim D. Ostrowski$387,4031 gr6Tara L McIsaac$384,3171 gr7Yohei Norimatsu$382,3431 gr8Vineet Kumar Singh$308,8741 gr

Largest grants

Respiratory dysfunction in Alzheimer's disease and its link to oxidative damage within the brain stem.$387,403
R15 · FY2021 · AG
Multi-limb Control in Parkinson's Disease: Implicit and Explicit Control of Attention$384,317
R15 · FY2017 · NS
Atomic-scale refinement of CFTR and TAAR1 molecular models for the study of drug binding$382,343
R15 · FY2018 · GM
Significance of four methionine sulfoxide reductases in Staphylococcus aureus$308,874
R15 · FY2010 · AI
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2003 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2002 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2001 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2005 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2004 · EY
Curriculum and Faculty Development in Evidence-based Medicine$219,349
R25 · FY2010 · AT
Curriculum and Faculty Development in Evidence-based Medicine$212,806
R25 · FY2012 · AT
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2001 · EY
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2000 · EY
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2002 · EY
Curriculum and Faculty Development in Evidence-based Medicine$210,490
R25 · FY2011 · AT
Curriculum and Faculty Development in Evidence-based Medicine$209,736
R25 · FY2007 · AT
LENS CHOLESTEROL METABOLISM AND THE U18666A CATARACT$209,645
R01 · FY2000 · EY
Curriculum and Faculty Development in Evidence-based Medicine$208,462
R25 · FY2013 · AT
Curriculum and Faculty Development in Evidence-based Medicine$205,541
R25 · FY2009 · AT
Curriculum and Faculty Development in Evidence-based Medicine$205,541
R25 · FY2008 · AT